Tissue kallikrein-like immunoreactive material decorates neuritic plaques of Alzheimer patients

Clinical Neuropathology

Volumn 16, Issue 2, 1997, Pages 69-71

  Bernstein, H G ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Alzheimer disease; human neocortex; immunohistochemistry; neuritic plaque; tissue kallikrein

Indexed keywords

KALLIKREIN;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SENILE PLAQUE;

ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; MALE; NEUROFIBRILLARY TANGLES; TISSUE KALLIKREINS; VASOCONSTRICTOR AGENTS;

EID: 0030966679     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aoyagi T, Wada T, Nagai M, Kojima F, Harada S, Takeuchi T, Takahashi H, Hirokawa K, Tsumita T 1990 Deficiency of kallikrein-like enzyme in cerebral tissue of patients with Alzheimer's disease. Experientia 46: 94-97
2. Bernstein H-G, Wiederanders B 1994 An immunohistochemical study of cathepsin E in Alzheimer-type dementia brains. Brain Res 667: 287-290
3. Bernstein H-G, Muller M 1995 Increased immunostaining for L-ornithine decarboxylase in neocortical neurons of Alzheimer's disease patients. Neurosci Lett 186: 123-126
4. Bernstein H-G, Kirschke H, Wiederanders B, Pollak K-H, Zipress A, Rinne A 1996 The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease. A review. Mol Chem Neuropathol 27: 225-247
5. Bhoola KD, Figueiro CD, Worthy K 1992 Bioregulators of kinins: kallikreins, kininogens and kininases. Pharmacol Rev 44: 1-80
6. Briggs JP, Martin-Grez M, Steipe B, Schubert G, Schnermann J 1984 Inactivation of atrial natriuretic substance by kallikrein. Am J Physiol 247: 480-484
7. Cardin AD, Witt KR, Chao J, Margolis HJ 1984 Degradation of apolipo-protein B-100 and of human plasma low-density lipoproteins by tissue and plasma kallikrein. J Biol Chem 259: 8522-8528
8. Cataldo AM, Nixon RA 1990 Enzymatically active lysosomal proteinases are associated with amyloid deposits in Alzheimer disease. Proc Natl Acad Sci USA 87: 3861-3865
9. Chao J, Chao L, Christopher C, Swain CC, Tsai J, Margolis HS 1987 Tissue kallikrein in rat brain and pituitary and its regional distribution and estrogen induction in the anterior pituitary. Endocrinology 120: 475-482
10. DeLa-Cadena RA, Sartor RB, Adam A, Raymond B, Legris F, Colman RW 1992 Role of kallikrein-kinin sytem in the pathogenesis of bacterial cell wall-induced inflammation and enterocolitis. Trans Assoc Am Physicians 105: 229-237
11. Francel PC 1992 Bradykinin and neuronal injury. J Neurotrauma 9 (Suppl 1): 27-45
12. Huang HM, Lin TA, Sun GY, Gibson GE 1995 Increased inositol 1,4,5-triphosphate accumulation correlates with an up-regulation of bradykinin receptors in Alzheimers disease. J Neurochem 64: 761-766
13. Kizuki T, Suzuki T, Tudo M, Noguchi T 1994a Immunohistochemical demonstration of tissue kallikrein in the neurons of rat brain. Brain Res 634: 305-309
14. Kizuki T, Suzuki T, Sugaya K, Noguchi T, Kudo M 1994b Tissue kallikrein in rat and mouse neurons. Braz J Med Biol Res 27: 1891-1896
15. McGeer P, McGeer EG 1995 The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21: 195-218
16. Nitsch RM, Slack BE, Farber SA, Schak JG, Deng M, Kim C, Borghesani PR, Korver W, Wurtman RJ, Growdon JH 1994 Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer disease in transfected cell lines and in brain slices. J Neural Transm Suppl 44: 21-27
17. Nitsch RM, Wurtman RJ, Growdon JH 1995 Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer's disease. Arzneimittelforschung 45: 435-438
18. Ole-Moi Yor O, Seldin, DC, Spragg J, Pinius G, Austen KF 1979 Sequential cleavage of proinsulin by human plasma kallikrein and a human pancreatic kininase. Proc Natl Acad Sci USA 76: 3612-3616
19. Schachter M 1980 Kallikrein (kininogenases) - a group of serine poteinases with bioregulatory actions. Pharmacol Rev 32: 1-17
20. Scich AG, Forbes G, Nolly H, Dujovny M, Carretto OA 1984 Kallikreins-kinins in the central nervous system. Part A: Theory and practice. Clin Exp Hypertens 6: 1731-1738
21. Sharma JN 1991 The role of the kallikrein-kinin system in joint inflammatory disease. Pharmacol Res 23: 105-112
22. Shisheva AC, Printz MP, Herman K, Ganten D 1985 Kinin-forming acticity in rat brain. Neurochem Int 7: 621-62
23. Simson JAV, Dom R, Chao J, Woodley C, Chao L, Margolis HS 1985 Immunocytochemical localization of tissue kallikrein in brain ventricular epithelium and hypothalamic cell bodies. J Histochem Cytochem 33: 951-953
24. Snyman C, Naidoo Y, Narotam PK, Figueroa CD, Van Dellen JR, Bhoola KD 1994 Cellular localization of atrial natriuretic peptide and tissue kallikrein in the human hypothalamus. Braz J Med Biol Res 27: 1877-1883
25. Sprumont P, Kaelin-Lang A, Van Lierde S, Maenhaut W, De Reuck J 1995 Effect of neurotropin on cerebral edema, calcium and other elements in mice subarachnoidally injected with carrageenan. Eur J Pharmacol 274: 95-99
26. Wiederanders B, Oelke B 1984 Accumulation of inactive cathepsin D in old rats. Mech Ageing Dev 24: 265-271